BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An JC, Shi HB, Hao WB, Zhu K, Ma B. miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting STAT1 interaction. Oncol Lett 2019;17:3790-8. [PMID: 30881499 DOI: 10.3892/ol.2019.10045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Shen J, Wang Q, Liang C, Su X, Ke Y, Mao Y, Fang J, Duan S. Novel Insights into miR-944 in Cancer. Cancers 2022;14:4232. [DOI: 10.3390/cancers14174232] [Reference Citation Analysis]
2 Liu X, Zeng W, Zheng D, Tang M, Zhou W. Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1. Mol Biotechnol 2022. [PMID: 35639278 DOI: 10.1007/s12033-022-00511-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rao X, Lu Y. C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells. Mol Biotechnol 2022. [PMID: 35578071 DOI: 10.1007/s12033-022-00495-z] [Reference Citation Analysis]
4 Jiang J, Lu J, Wang X, Sun B, Liu X, Ding Y, Gao G. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling. Aging (Albany NY) 2021;13:19243-59. [PMID: 34233294 DOI: 10.18632/aging.203243] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Zhu X, Guo Q, Zou J, Wang B, Zhang Z, Wei R, Zhao L, Zhang Y, Chu C, Fu X, Li X. MiR-19a-3p Suppresses M1 Macrophage Polarization by Inhibiting STAT1/IRF1 Pathway. Front Pharmacol 2021;12:614044. [PMID: 34017248 DOI: 10.3389/fphar.2021.614044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
6 Zhu H, Lu Q, Lu Q, Shen X, Yu L. Matrine Regulates Proliferation, Apoptosis, Cell Cycle, Migration, and Invasion of Non-Small Cell Lung Cancer Cells Through the circFUT8/miR-944/YES1 Axis. Cancer Manag Res 2021;13:3429-42. [PMID: 33907466 DOI: 10.2147/CMAR.S290966] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
7 Lv J, Li Q, Ma R, Wang Z, Yu Y, Liu H, Miao Y, Jiang S. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis. Technol Cancer Res Treat 2021;20:1533033821990090. [PMID: 33550920 DOI: 10.1177/1533033821990090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance. Onco Targets Ther 2020;13:6037-50. [PMID: 32606809 DOI: 10.2147/OTT.S256708] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Xia J, Li D, Zhu X, Xia W, Qi Z, Li G, Xu Q. Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion. Oncol Lett 2020;19:3578-86. [PMID: 32269632 DOI: 10.3892/ol.2020.11457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
10 Wang W, Liu B, Duan X, Feng X, Wang T, Wang P, Ding M, Zhang Q, Feng F, Wu Y, Yao W, Wang Q, Yang Y. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis. Comb Chem High Throughput Screen 2020;23:148-56. [PMID: 31976830 DOI: 10.2174/1386207323666200124123103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]